SLC6A16
Orphan sodium- and chloride-dependent neurotransmitter transporter NTT5
Also known as: NTT5, S6A16_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9GZN6
- Gene
- SLC6A16
- Ensembl
- ENSG00000063127
- Chromosome
- 19
- Canonical length
- 736 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Golgi apparatus
OverviewNCBI Gene
SLC6A16 shows structural characteristics of an Na(+)- and Cl(-)-dependent neurotransmitter transporter, including 12 transmembrane (TM) domains, intracellular N and C termini, and large extracellular loops containing multiple N-glycosylation sites.[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
736 residues, UniProt reviewed canonical sequence.
>Q9GZN6|SLC6A16
1 MKTEAQPSTS LLANTSWTGT VISDSVPGSQ TWEDKGSLTR SATSWTSEAQ VSAARVAEAQ
61 ARTSQPKQIS VLEALTASAL NQKPTHEKVQ MTEKKESEVL LARPFWSSKT EYILAQVGFS
121 MKPSCLWRFA YLWLNSGGCS FAAIYIFMLF LVGVPLLFLE MAAGQSMRQG GMGVWKIIAP
181 WIGGVGYSSF MVCFILGLYF NVVNSWIIFY MSQSFQFPVP WEKCPLTMNS SGFDPECERT
241 TPSIYFWYQQ ALKASDRIED GGSPVYSLVL PFFLCWCLVG AFMINGLKST GKVIYVLVLL
301 PCFIIVGFFI RTLLLEGAKF GLQQLVVAKI SDVYNMSVWS LAGGQVLSNT GIGLGSVASL
361 ASYMPQSNNC LSDAFLVSVI NLLTLLVFTS FNFCVLGFWA TVITHRCCER NAEILLKLIN
421 LGKLPPDAKP PVNLLYNPTS IYNAWLSGLP QHIKSMVLRE VTECNIETQF LKASEGPKFA
481 FLSFVEAMSF LPPSVFWSFI FFLMLLAMGL SSAIGIMQGI ITPLQDTFSF FRKHTKLLIV
541 GVFLLMFVCG LFFTRPSGSY FIRLLSDYWI VFPIIVVVVF ETMAVSWAYG ARRFLADLTI
601 LLGHPISPIF GWLWPHLCPV VLLIIFVTMM VHLCMKPITY MSWDSSTSKE VLRPYPPWAL
661 LLMITLFAIV ILPIPAYFVY CRIHRIPFRP KSGDGPMTAS TSLPLSHQLT PSKEVQKEEI
721 LQVDETKYPS TCNVTSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC6A16 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 12
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 88 nTPM
Expression across tissuesHPA
Tissue
- testis: 88 nTPM
- choroid plexus: 15 nTPM
- liver: 9.4 nTPM
- blood vessel: 9.2 nTPM
- kidney: 7.1 nTPM
- ovary: 6.8 nTPM
Single-cell type
- late primary spermatocytes: 252 nCPM
- early primary spermatocytes: 180 nCPM
- ependymal cells: 128 nCPM
- choroid plexus epithelial cells: 127 nCPM
- early spermatids: 102 nCPM
- respiratory ciliated cells: 72 nCPM
Immune cell
- memory B-cell: 4.5 nTPM
- eosinophil: 2.6 nTPM
- naive B-cell: 2.2 nTPM
- non-classical monocyte: 2.1 nTPM
- neutrophil: 1.8 nTPM
- NK-cell: 1.8 nTPM
Brain region
- choroid plexus: 38 nTPM
- medulla oblongata: 12 nTPM
- midbrain: 12 nTPM
- pons: 11 nTPM
- spinal cord: 8 nTPM
- amygdala: 7.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.09
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.99
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC6A16 as an antibody target. Whether an autoantibody or antibody against SLC6A16 could matter depends on whether native SLC6A16 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC6A16 is annotated at the cell surface, where native SLC6A16 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC6A16 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...